12:00 AM
 | 
Mar 18, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Results

EV71 vaccine: Phase III data

Sinovac Biotech Ltd. (NASDAQ:SVA), Beijing, China
Product: EV71 vaccine
Business: Infectious
Molecular target: Not applicable
Description: Vaccine against human enterovirus 71 (EV71)
Indication: Vaccinate against hand, foot and mouth disease (HFMD) caused by EV71
Endpoint: Incidence of disease at...

Read the full 183 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >